Drug · DIN 00358177
MAXITROL
OINTMENT
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since March 18, 2019; first marketed December 31, 1970.
- Drug Identification Number (DIN)
- 00358177
- Company (DIN owner)
- Novartis Pharmaceuticals Canada Inc.Montreal, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Ointment
- Route
- Ophthalmic
- Therapeutic class (ATC)
- Dexamethasone and antiinfectives S01CA01
- Class
- Human
- Record last updated
- August 26, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| DEXAMETHASONE | 0.1 % | W/W |
| NEOMYCIN (NEOMYCIN SULFATE) | 3.5 MG | G |
| POLYMYXIN B SULFATE | 6000 UNIT | G |
Other DINs named MAXITROL
- DIN 00042676 · Marketed